Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Smoking Cessation 2Neoplasms 2Lung Neoplasms 2Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Neoplasm Metastasis 1Motor Activity 1Lymphoma 1Leukemia 1Inflammation 1Colorectal Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Capecitabine 13Fluorouracil 12Oxaliplatin 9Nivolumab 9Radiotherapy 8Leucovorin 8Cetuximab 8Magnetic Resonance Spectroscopy 6Irinotecan 5pembrolizumab 4encorafenib 4Surgical Procedures, Operative 4Sigmoidoscopy 4Radiotherapy, Intensity-Modulated 4Surveys and Questionnaires 3Standard of Care 3Specimen Handling 3Biopsy 3Bevacizumab 3dostarlimab 2dehydroftorafur 2atezolizumab 2XELOX 2X-Rays 2Observation 2Magnetic Resonance Imaging 2Immunoglobulin G 2Folfox protocol 2Drug Therapy 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Rectal Neoplasms × Hematologic Tests × Clear all
NCT06730035 2024-12-12

PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase NA Active not recruiting
30 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡